Jianqiang Cai

Adjuvant sorafenib for hepatocellular carcinoma after resection or ablation (STORM): a phase 3, randomised, double-blind, placebo-controlled trial

Jordi Bruix, Tadatoshi Takayama, Vincenzo Mazzaferro et al. · The Lancet Oncology · 2015 · 1.1K citations

Surgical Oncology, Hepatology, Medicine +8

Guidelines for the Diagnosis and Treatment of Hepatocellular Carcinoma (2019 Edition)

Jian Zhou, Hui‐Chuan Sun, Zheng Wang et al. · Liver Cancer · 2020 · 813 citations · Full text

Inactivating mutations of the chromatin remodeling gene ARID2 in hepatocellular carcinoma

Meng Li, Hong Zhao, Laura D. Wood et al. · Nature Genetics · 2011 · 421 citations · Full text

Chromatin, Tumor Biology, Chromatin Structure +13

Safety and Efficacy of Anlotinib, a Multikinase Angiogenesis Inhibitor, in Patients with Refractory Metastatic Soft-Tissue Sarcoma

Yihebali Chi, Zhiwei Fang, Xiaonan Hong et al. · Clinical Cancer Research · 2018 · 322 citations

Detection of early-stage hepatocellular carcinoma in asymptomatic HBsAg-seropositive individuals by liquid biopsy

Chunfeng Qu, Yuting Wang, Pei Wang et al. · Proceedings of the National Academy of Sciences · 2019 · 174 citations · Full text

Asymptomatic Hbsag-seropositive Individuals, Pathology, Hepatic Disorders +26